{"name":"M. Medici","slug":"m-medici","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LT3 (liothyronine)","genericName":"LT3 (liothyronine)","slug":"lt3-liothyronine","indication":"Hypothyroidism (replacement therapy)","status":"phase_3"}]}],"pipeline":[{"name":"LT3 (liothyronine)","genericName":"LT3 (liothyronine)","slug":"lt3-liothyronine","phase":"phase_3","mechanism":"Liothyronine is a synthetic form of triiodothyronine (T3) that binds to thyroid hormone receptors to increase metabolic rate and cellular energy production.","indications":["Hypothyroidism (replacement therapy)","Myxedema coma (acute severe hypothyroidism)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQVGMyU3hqM244bVBfMGp4TWliLVZjVGpQM0pub2prTXZTQlVva1hEVWVxTUtIbzRqVEpuY3ROMHJMak9DS1V5Q1Y4NVc1Sjc3cmxPSWRPNTU0ZWRuZ3pYT2Z1Y2FQLUhmbGJpWE9PemVGTFQybDVyVkhWN1hnbXlFWHNQYWdnQkQ4TGtNSThJUmM2S1N6Smh4S1Zhb1lldVV0NU1GWmtMMEVncm1LRGt3akxoV3kzeTNJZGRKLTV2bzIyUjNjOTFxOWMzYW1BZUh5a0FnX3NHSWV1eHVFUjZOR3pHOVRkWDlwVmR2eS0tWmw?oc=5","date":"2026-03-26","type":"pipeline","source":"Shiksha.com","summary":"Career After M Pharma: A Complete Guide on Career Options After Master of Pharmacy - Shiksha.com","headline":"Career After M Pharma: A Complete Guide on Career Options After Master of Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQejdCYUQ5dzRaVkQ2UG5MLUFvOW9oQVM5ckh4TEt3SkJFWHhJTk0wZ29xVi1zcEhFVXRQLWxxYjlGNDQwdlVrZVpJSzRGcFVLcW9tUG1LSEhHOGNpUnhVMzk0UVRpd0ViY2d0dURFWDNPd0VpdHktSTVPSWY2SWFOR0pqMWlfVjVPYzlzc29zdTZ4N0xXb2VpY1lR?oc=5","date":"2026-03-25","type":"pipeline","source":"Britannica","summary":"Genetically modified organism - Medicine, Research, Biotechnology - Britannica","headline":"Genetically modified organism - Medicine, Research, Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQQ20zd2RNczhFSzFxQWZJWEVfcWVUTEU0aEFtWmU2NElOM0VVNUM3ZEFIRDdxaGt4UVJVWkE5QkZic2l3Slo4VzIwbW1wQTJ6WEpDaGU1NWItdGJDX0NmeTV1THdpNnM5NWlBOERYWE5lb2pZVllvU1JQdWJVUC1GYUw2TExQV2RSNG1LUE1tWjVqd05fckZTYmt5eFRVVFRwTkVmbGVYTDJmUWNOYWYxbGRPZDY?oc=5","date":"2026-01-27","type":"pipeline","source":"fiercebiotech.com","summary":"Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance - fiercebiotech.com","headline":"Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQU3dFNDhobVBPaGxaZnlqUEFhYXEwVjdNVFI4eE9iYUdJZjU0QzRIaUFuam42dFd1azZXVU81Y0hhX3lKb3dCcTJ0OWQtVHV0YUswSEhUdlFOUm5tYzNKMVFHa0I5TEM0UzVSLUJzN0RPWThPRjlnbW4wSzlBN1hnTE5qLUdITzA?oc=5","date":"2026-01-05","type":"deal","source":"pharmaphorum","summary":"Insilico adds Servier to partnership roster with $888m deal - pharmaphorum","headline":"Insilico adds Servier to partnership roster with $888m deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNOGw2Y3JueVhZYnRLQ2d5REdLT243NG9JSGxycmhDaUN2eVlfR1BqWHNWdThJbmhCUWlhT2pielo0MFVrN1ZhZm9hSXFqMTlIRDQxVXB0TV9lQzNrSVpMbGhOXzFkbEEtU1drR3ktcnlwNnhxMmJUcml5S1VDRm5tR0hKWQ?oc=5","date":"2026-01-04","type":"deal","source":"Insilico Medicine","summary":"AI-Powered R&D Acceleration: Insilico Medicine and Hisun Pharma Nominate a Preclinical Candidate Just 8 Months After Forming a Strategic Collaboration - Insilico Medicine","headline":"AI-Powered R&D Acceleration: Insilico Medicine and Hisun Pharma Nominate a Preclinical Candidate Just 8 Months After For","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1pZmxkbzJiRUhBMEVWYnNGWHpjZmd4MFlqSnNRV2J3ZmFheHBLbE9lYVhDYUQyN3lHS3BWRVZ5VU1aLVJZSEdLbi1WNFh4c0R4aDRGRDNsejdkZWFFLUdYbnVlN2ZXcktzSnhTczV4Uk5oWEtpQ3c?oc=5","date":"2025-12-31","type":"pipeline","source":"pharmaphorum","summary":"Insilico ends 2025 with $293m Hong Kong IPO - pharmaphorum","headline":"Insilico ends 2025 with $293m Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPWlMzLW5QRkYyRjE1WWNlRHR3OVMwZ2U3c0NiVlh0b2Z4R2FVR3J2ZWotTk01bXVjSGlLSjdQM3k3eExta1NlQkhTR2tGMGdaVm1KUGtGaVRpZHo3dWs0b183MzA5WTh6M2hLWllXSFNHTjVfbUtNZ2E5SVhSYW1veGtDcWpSYUl2aHUzOGNSMA?oc=5","date":"2025-10-20","type":"pipeline","source":"news.osu.edu","summary":"College of Pharmacy dean elected to National Academy of Medicine - news.osu.edu","headline":"College of Pharmacy dean elected to National Academy of Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQSVdWbTc3STFzYW5BUU9oNG1ldnp4ZWN2Z3ZrMHJLXy1tbnJKaDZmSmtfY0w5QjdDdFozWk13cTJ1ZGJFdmk1SXZ3VnFHangzaUdfZUxoa3MwQVgyMGsteHBFS2t4NUhYUHNoajRWclRDYmlyU2hCdHRwbU9NY1czSjdtVG1aQ00wX3V0RXd3?oc=5","date":"2025-09-29","type":"pipeline","source":"Frontiers","summary":"A scoping review on the impact of versatile Digital Health innovations on pharmacy education - Frontiers","headline":"A scoping review on the impact of versatile Digital Health innovations on pharmacy education","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNUE5uUEw2UkZPN2FRWWZTbFJfREZkc2w0eHpYZDdLbHJJckxVSm1xdlRKV0hOSUpnYjNCWGdiNXNtWUZIa29GdlpwS3BYM1hnRFJscS1sRElxcERQUW5uWU9KdkNYUVQxX1lZd1hkbHZsc1dwNTFqRklKOU53MkNXRWRZVVRMWTNKWHg4c1JabGdsQ3Y2a3FZ?oc=5","date":"2025-06-18","type":"pipeline","source":"BioPharma Dive","summary":"A startup banks $66M to pursue ‘inclusive precision medicine’ - BioPharma Dive","headline":"A startup banks $66M to pursue ‘inclusive precision medicine’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOTlVHeXQ2b185WUc2eXFacnlia2FZQlZKMDNUSlZneWpFZk91UG1XcUQzbW5tZnA2LVU1ekpUMW9SOFY0blFsSGxNQXlmS3RZM1dYakc1RW9xT2ZFbmFwUnIyWFpuYUNDM2o3MnJvV2hxVW5qbzk3cVhfT0poWk9Sbm5uamxLMlVJUmpxVlhYQUdyemJybHlzVkw4M3duZGNxZlB5QXh4MUYyTjFvTndLOTNZNA?oc=5","date":"2025-05-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Stylus Medicine launches with $85m to advance in vivo gene editing - Pharmaceutical Technology","headline":"Stylus Medicine launches with $85m to advance in vivo gene editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPT3BpRENWVUtvQ0lKakVHbWN3T3prdHVlYVQ2VkFnZWtXM25xTkVUZFk1Mm4zQy1lRzl5TjRJNkk2bkw5NUYyQ285WWk3VHRQMUxuYUNEeHRSZHlFVjdFOEdEZ1BPMThEcjN1WG5Ic3BCMHo2bHhnSS1hNllhbUQ2OUVQbHdQSzlONjNWR0cwaWhwdmJ0ZVIzNzNBTXZ6MVBuTERmRm9JRW1iYXhxUlp4X201eVlUVTBldEJKUlRZWXFuU0RQOGxRc09wMFIxQVMyYVFRckdlbTBHeEdYNmt1NTk3VFg?oc=5","date":"2023-06-09","type":"pipeline","source":"The Conversation","summary":"‘From Magic Mushrooms to Big Pharma’ – a college course explores nature’s medicine cabinet and different ways of healing - The Conversation","headline":"‘From Magic Mushrooms to Big Pharma’ – a college course explores nature’s medicine cabinet and different ways of healing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE10M041NF92MjA2bGhsMGM1UTdKS0w2OS0xMC1yNmVwMGI2bmUxdHNNRkJ4clI3TXV0SFpCd2dHRXZaclBKTG1UR2tZM2NBMjNxZFBCUkFmblJxMEphaDNZ?oc=5","date":"2022-05-10","type":"pipeline","source":"Nature","summary":"Adverse effects of acquisitions in the pharmaceutical industry - Nature","headline":"Adverse effects of acquisitions in the pharmaceutical industry","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}